Related references
Note: Only part of the references are listed.Japanese Encephalitis Vaccine (Inactivated, Adsorbed) [IXIARO (R)]
Sean T. Duggan et al.
DRUGS (2009)
Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: A randomized, observer-blind, controlled Phase 3 study
Elisabeth Schuller et al.
VACCINE (2009)
Japanese encephalitis vaccine in travelers
Tomas Jelinek
EXPERT REVIEW OF VACCINES (2008)
Japanese encephalitis in a Finnish traveler on a two-week holiday in Thailand
Ville A. Lehtinen et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine
E. Tauber et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
New vaccines for Japanese encephalitis
Tom Solomon
LANCET NEUROLOGY (2008)
Long-term immunogenicity of the new Vero cell-derived, inactivated Japanese encephalitis virus vaccine IC51 Six and 12 month results of a multicenter follow-up phase 3 study
E. Schuller et al.
VACCINE (2008)
Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51
Elisabeth Schuller et al.
VACCINE (2008)
Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants
Salvacion Gatchalian et al.
VACCINE (2008)
Current use and development of vaccines for Japanese encephalitis
David W. C. Beasley et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2008)
Safety and immunogenicity of a Vero-cell-derived,inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial
E. Tauber et al.
LANCET (2007)
Japanese encephalitis for a reference to international travelers
Akira Oya et al.
JOURNAL OF TRAVEL MEDICINE (2007)
Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: A case-control study in Nepalese children 5 years after immunization
J. B. Tandan et al.
VACCINE (2007)
A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis
Arthur Lyons et al.
VACCINE (2007)
High antibody prevalence in an unconventional ecosystem is related to circulation of a low-virulent strain of Japanese encephalitis virus
Shyan-Song Chiou et al.
VACCINE (2007)
Duration of neutralizing antibody titer after Japanese encephalitis vaccination
Motoharu Abe et al.
MICROBIOLOGY AND IMMUNOLOGY (2007)
Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004
J Hombach et al.
VACCINE (2005)
An assessment of the interval between booster doses of Japanese encephalitis vaccine in the Torres Strait
JN Hanna et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH (2005)
Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine
DWC Beasley et al.
VACCINE (2004)
Immunogenicity and safety of a booster vaccination against tick-borne encephalitis more than 3 years following the last immunisation
P Rendi-Wagner et al.
VACCINE (2004)
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): Phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen
TP Monath et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Interferon alfa-2a in Japanese encephalitis: a randomised double-blind placebo-controlled trial
T Solomon et al.
LANCET (2003)
Origin and evolution of Japanese encephalitis virus in southeast Asia
T Solomon et al.
JOURNAL OF VIROLOGY (2003)
Allergic reactions to Japanese encephalitis vaccine
AM Plesner
IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2003)
Development of Vero cell-derived inactivated Japanese encephalitis vaccine
K Sugawara et al.
BIOLOGICALS (2002)
Japanese encephalitis vaccine for travelers: Exploring the limits of risk
DR Shlim et al.
CLINICAL INFECTIOUS DISEASES (2002)
Factors influencing the abundance of Japanese encephalitis vectors in ricefields in India - I. Abiotic
IP Sunish et al.
MEDICAL AND VETERINARY ENTOMOLOGY (2001)
A purified inactivated Japanese encephalitis virus vaccine made in vero cells
AK Srivastava et al.
VACCINE (2001)
Specific IgE and IgG to gelatin in children with systemic cutaneous reactions to Japanese encephalitis vaccines
M Sakaguchi et al.
ALLERGY (2001)
Share Paper
